Shares of XBiotech Inc. (NASDAQ:XBIT – Get Free Report) passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $7.45 and traded as high as $8.39. XBiotech shares last traded at $8.21, with a volume of 45,963 shares.
Wall Street Analyst Weigh In
Separately, StockNews.com initiated coverage on XBiotech in a research note on Thursday, February 15th. They issued a “sell” rating for the company.
Read Our Latest Report on XBiotech
XBiotech Price Performance
XBiotech (NASDAQ:XBIT – Get Free Report) last posted its quarterly earnings data on Friday, March 15th. The biopharmaceutical company reported ($0.16) earnings per share (EPS) for the quarter.
Hedge Funds Weigh In On XBiotech
An institutional investor recently bought a new position in XBiotech stock. National Bank of Canada FI acquired a new position in XBiotech Inc. (NASDAQ:XBIT – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 24,347 shares of the biopharmaceutical company’s stock, valued at approximately $103,000. National Bank of Canada FI owned approximately 0.08% of XBiotech at the end of the most recent quarter. 55.70% of the stock is owned by institutional investors and hedge funds.
XBiotech Company Profile
XBiotech Inc, a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation.
Featured Stories
- Five stocks we like better than XBiotech
- Are Penny Stocks a Good Fit for Your Portfolio?
- Hasbro’s Management Made All the Right Calls This Quarter
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- Industrial Products Stocks Investing
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for XBiotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XBiotech and related companies with MarketBeat.com's FREE daily email newsletter.